Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 2, 2006, Pages 189-193

  Muta, Hiromi ^a,e   Ishii, Masahiro ^b   Furui, Jun ^c   Nakamura, Yosikazu ^d   Matsuishi, Toyojiro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e NONE   (Japan)

Author keywords

Cardiovascular complications; Gamma globulin; Kawasaki disease

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CERVICAL LYMPHADENOPATHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; JAPAN; LIP DISEASE; MAJOR CLINICAL STUDY; MALE; MOUTH LESION; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EXANTHEMA; FEMALE; GAMMA-GLOBULINS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LOGISTIC MODELS; LYMPHATIC DISEASES; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECURRENCE; RISK FACTORS;

EID: 31944441023     PISSN: 08035253     EISSN: 15023869     Source Type: Journal    
DOI: 10.1080/08035250500327328     Document Type: Article

References (21)

1. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile MCLNS. J Pediatr 1975;86:892-8.
2. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the ringers and toes in children. Arerugi 1967;16:178-222 [in Japanese].
3. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7.
4. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma-globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
5. Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, et al. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness. Pediatr Int 1999;41:1-7.
6. Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 1993;123:657-9.
7. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J 1998;17:1144-8.
8. Ran RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 2000;154:694-9.
9. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105: Available from URL: http://www.pediatrics.org/cgi/content/full/105/6/e78
10. Fukunishi M, Kikkawa M, Hamana K, Onodera T, Matsuzaki K, Matumoto Y. Prediction of non-response to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000;137:172-6.
11. Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 2003;24:145-8.
12. Sundel RP, Baker AL, Fulton DR, Newburger JW Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr 2003;142:611-6.
13. Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 1999;135:465-9.
14. The Japan Kawasaki Disease Research Committee. Diagnostic guidelines of Kawasaki disease, the 5th revised edition. Tokyo: Kawasaki Disease Research Committee; 2002.
15. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferried P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1633-9.
16. Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo: Ministry of Health and Welfare; 1994.
17. Muta H, Ishii M, Egami K, Furui J, Sugahara Y, Akagi T, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr 2004;144:496-9.
18. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10.
19. Daniels S, Specker B, Capannari T, Schwartz DC, Burke MJ, Kaplan S. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. Am J Dis Child 1987;141:205-7.
20. Nakamura Y, Oki Y, Tanihara S, Ojima T, Yanagawa H. Cardiac sequelae in recurrent cases of Kawasaki disease: comparison between the initial episode of the disease and a recurrence in the same patients. Pediatrics 1998;102: Available from URL: http://pediatrics.aappublications.org/cgi/content/full/102/ 6/e66
21. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel R, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998;133:254-8.